Clinical Trials List
2022-12-15 - 2026-12-31
Phase III
Not yet recruiting5
Recruiting4
ICD-10J12.0
Adenoviral pneumonia
ICD-9480.0
Pneumonia due to adenovirus
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Wei-An Chang 無
- 馬瑞陽 無
- Chun-Yuan Lee 無
- 莊政皓 無
- jong rung Tsai 無
- 陳家閔 無
- 李玫萱 無
- 張雅婷 無
- 王程遠 無
- 鄭至宏 無
- KUAN-LI WU 無
- Shang-Yi Lin 無
- 邱昱堯 未分科
- 鄭孟軒 無
- Ming-Ju Tsai 無
- 許恩齊 無
- 蔡毓德 無
- Chih-Jen Yang 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 張可昀 無
- 廖培雅 無
- Wei- Chang Huang 無
- YEN-HSIANG HUANG 無
- 王俊隆 無
- 林雋 無
- 歐偉凡 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Jia-Yih Feng 無
- 黃仲儒 無
- 潘聖衛 無
- 余文光 無
- Kang-Cheng Su 無
- Chi-Lu Chiang 無
- Wei-Zhi Chen 無
- 周昆達 無
- Hsu-ching Huang 無
- 周中偉 無
- Chia-I Shen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 莊立邦 無
- Meng-Jer Hsieh 無
- 黃建達 無
- 林諄語 無
- Shih-Wei Lin 無
- 張博瑞 無
- 羅君禹 無
- Shu-Min Lin 無
- 呂紹煒 無
- Ko-Wei Chang 無
- 謝孟亨 無
- Chih-Hung Chen 無
- Kuo-Chin Kao 無
- 胡漢忠 無
- 邱立忠 無
- Chien-Ying Liu 無
- 洪禎佑 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Fu-Lun Chen Division of Infectious Disease
- 許金旺 Division of Emergency Medicine
- Yu-Tien Tzeng Division of Thoracic Medicine
- 石智元 Division of Thoracic Medicine
- Chih-Hsin Lee Division of Thoracic Medicine
- 徐士昌 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Jung-Yien Chien 無
- 劉旺達 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ho Mao-Wang 無
- 余紹華 無
- 施宏謀 無
- Yu-Chao Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
2870 participants